INBRAIN reports positive interim results from its first-in-human graphene interface study

INBRAIN Neuroelectronics/Graphene brain interface

Interim results from the first four patients in INBRAIN's first-in-human graphene brain interface study showed no device-related adverse events. During awake brain-tumour surgery the ultra-thin graphene electrodes picked up distinct high-frequency activity linked to individual speech sounds and worked with standard hospital recording systems; full enrolment planned for 8 to 10 patients.

• Interim data from first four patients showed no device-related adverse events.
• Ultra-thin graphene electrodes detected distinct high-frequency activity tied to individual speech sounds.
• Electrodes compatible with standard hospital recording systems; study expanding to 8-10 total patients.